These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3874792)
1. [The effects of o,p'-DDD on adrenal steroidogenesis and hepatic steroid metabolism]. Ojima M; Saitoh M; Itoh N; Kusano Y; Fukuchi S; Naganuma H Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):168-78. PubMed ID: 3874792 [TBL] [Abstract][Full Text] [Related]
2. [The effects of o,p'-DDD on human adrenal steroid synthesis]. Ojima M; Saito M; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274 [TBL] [Abstract][Full Text] [Related]
3. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers. Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292 [TBL] [Abstract][Full Text] [Related]
4. Treatment with o,p'-DDD (mitotane) decreased cytochrome P-450, heme, and microsomal protein content in the dog adrenal cortex in vivo. Martz F; Straw JA Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):83-92. PubMed ID: 1257603 [TBL] [Abstract][Full Text] [Related]
5. [Effects of o,p'-DDD on pituitary-gonadal function in patients with Cushing's disease]. Ojima M; Hashimoto S; Itoh N; Kusano Y; Satoh K; Egawa M; Gomibuchi T; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1988 Jun; 64(6):451-62. PubMed ID: 3145221 [TBL] [Abstract][Full Text] [Related]
6. [The effects of canrenone K (soldactone) on the adrenocortical steroidogenic enzymes in the bovine adrenal gland]. Naganuma H; Sasano N; Ojima M Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):149-57. PubMed ID: 3486786 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid and mineralocorticoid pathways in two adrenocortical carcinomas: comparison of the effects of o,p'-dichlorodiphenyldichloroethane, aminoglutethimide and 2-p-aminophenyl-2-phenylethylamine in vitro. Touitou Y; Bogdan A; Auzeby A; Dommergues JP J Endocrinol; 1979 Jul; 82(1):87-94. PubMed ID: 479738 [TBL] [Abstract][Full Text] [Related]
8. [Changes in mitochondrial and microsomal electron transport as affected by o,p'-dichlorodiphenyldichloroethane]. Komissarenko VP; Mikosha AS; Chelnakova IS Ukr Biokhim Zh (1978); 1981; 53(6):74-7. PubMed ID: 6798728 [TBL] [Abstract][Full Text] [Related]
9. [Activity of glutathione reductase in the adrenal glands and the liver of dogs after administration O,P-DDD, perthane and ACTH]. Komissarenko VP; Chelnakova IS; Mikosha AS Probl Endokrinol (Mosk); 1978; 24(1):95-8. PubMed ID: 204922 [TBL] [Abstract][Full Text] [Related]
10. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells. Asp V; Cantillana T; Bergman A; Brandt I Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879 [TBL] [Abstract][Full Text] [Related]
11. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals. Moore RN; Penney DP; Averill KT Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928 [TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effects of glycyrrhizin and glycyrrhetinic acid on the metabolism of cortisol and prednisolone--in vivo and in vitro studies]. Ojima M; Satoh K; Gomibuchi T; Itoh N; Kin S; Fukuchi S; Miyachi Y Nihon Naibunpi Gakkai Zasshi; 1990 May; 66(5):584-96. PubMed ID: 2384181 [TBL] [Abstract][Full Text] [Related]
13. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009 [TBL] [Abstract][Full Text] [Related]
14. The effect of ketoconazole on steroidogenesis. II. Adrenocortical enzyme activity in vitro. Albertson BD; Maronian NC; Frederick KL; DiMattina M; Feuillan P; Dunn JF; Loriaux DL Res Commun Chem Pathol Pharmacol; 1988 Jul; 61(1):27-34. PubMed ID: 3175341 [TBL] [Abstract][Full Text] [Related]
15. [Properties of adrenocortical isocitrate dehydrogenase]. Mikosha AS; Monissarenko VP; Bychkovskaia LA Vopr Med Khim; 1981; 27(6):736-9. PubMed ID: 7336646 [TBL] [Abstract][Full Text] [Related]
16. o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis. Touitou Y; Moolenaar AJ; Bogdan A; Auzéby A; Luton JP Eur J Clin Pharmacol; 1985; 29(4):483-7. PubMed ID: 4092727 [TBL] [Abstract][Full Text] [Related]
17. [Insensitivity of purified glutathione reductase from adrenal cortex to o,p'-dichlorodiphenyldichloroethane]. Komissarenko VP; Chelnakova IS; Mikosha AS Ukr Biokhim Zh (1978); 1982; 54(4):400-4. PubMed ID: 7135497 [TBL] [Abstract][Full Text] [Related]
18. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro. Theile D; Haefeli WE; Weiss J Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and binding of mitotane in adrenal cortex homogenates. Cai W; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL J Pharm Sci; 1995 Feb; 84(2):134-8. PubMed ID: 7738789 [TBL] [Abstract][Full Text] [Related]
20. In vitro biotransformations of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DD) and 1,1-bis(p-chlorophenyl)-2,2-dichloroethane (p,p'-DDD) by bovine adrenal. Reif VD; Littleton BC; Sinesheimer JE J Agric Food Chem; 1975; 23(5):996-9. PubMed ID: 1159206 [No Abstract] [Full Text] [Related] [Next] [New Search]